» Articles » PMID: 35096836

HDAC6 Interacts With Poly (GA) and Modulates Its Accumulation in C9FTD/ALS

Abstract

The aberrant translation of a repeat expansion in chromosome 9 open reading frame 72 (), the most common cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), results in the accumulation of toxic dipeptide repeat (DPR) proteins in the central nervous system We have found that, among the sense DPR proteins, HDAC6 specifically interacts with the poly (GA) and co-localizes with inclusions in both patient tissue and a mouse model of this disease (c9FTD/ALS). Overexpression of HDAC6 increased poly (GA) levels in cultured cells independently of HDAC6 deacetylase activity, suggesting that HDAC6 can modulate poly (GA) pathology through a mechanism that depends upon their physical interaction. Moreover, decreasing HDAC6 expression by stereotaxic injection of antisense oligonucleotides significantly reduced the number of poly (GA) inclusions in c9FTD/ALS mice. These findings suggest that pharmacologically reducing HDAC6 levels could be of therapeutic value in c9FTD/ALS.

Citing Articles

Preclinical validation of a novel brain-penetrant PET ligand for visualization of histone deacetylase 6: a potential imaging target for neurodegenerative diseases.

Tago T, Sakata M, Kanazawa M, Yamamoto S, Ishii K, Toyohara J Eur J Nucl Med Mol Imaging. 2024; 51(8):2193-2203.

PMID: 38441662 DOI: 10.1007/s00259-024-06666-1.


Screens in aging-relevant human ALS-motor neurons identify MAP4Ks as therapeutic targets for the disease.

Liu M, Ma S, Tai W, Zhong X, Ni H, Zou Y Cell Death Dis. 2024; 15(1):4.

PMID: 38177100 PMC: 10766628. DOI: 10.1038/s41419-023-06395-7.


Autophagy and neurodegeneration: Unraveling the role of C9ORF72 in the regulation of autophagy and its relationship to ALS-FTD pathology.

Diab R, Pilotto F, Saxena S Front Cell Neurosci. 2023; 17:1086895.

PMID: 37006471 PMC: 10060823. DOI: 10.3389/fncel.2023.1086895.

References
1.
Mackenzie I, Frick P, Grasser F, Gendron T, Petrucelli L, Cashman N . Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol. 2015; 130(6):845-61. DOI: 10.1007/s00401-015-1476-2. View

2.
Chew J, Gendron T, Prudencio M, Sasaguri H, Zhang Y, Castanedes-Casey M . Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science. 2015; 348(6239):1151-4. PMC: 4692360. DOI: 10.1126/science.aaa9344. View

3.
Mackenzie I, Frick P, Neumann M . The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathol. 2013; 127(3):347-57. DOI: 10.1007/s00401-013-1232-4. View

4.
Mori K, Arzberger T, Grasser F, Gijselinck I, May S, Rentzsch K . Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 2013; 126(6):881-93. DOI: 10.1007/s00401-013-1189-3. View

5.
Verdel A, Curtet S, Lemercier C, Garin J, Rousseaux S, Khochbin S . Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways. Mol Cell Biol. 2001; 21(23):8035-44. PMC: 99970. DOI: 10.1128/MCB.21.23.8035-8044.2001. View